D-0611-2017 Class II Terminated
FDA drug recall D-0611-2017 was initiated by Sun Pharmaceutical Industries, Inc. on Mar 15, 2017 and is designated Class II. Reason for recall: Presence of Particulate Matter The recall status is terminated (terminated Apr 23, 2018). Affected quantity: 83,188 single does vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 29, 2017
- Initiation Date
- Mar 15, 2017
- Termination Date
- Apr 23, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 83,188 single does vials
Product description
Testosterone Cypionate Injection , USP, 200 mg/mL, 1 mL vial , For Intramuscular Use Only, Rx Only, Distributed by Sun Pharma Ind. Inc., NJ 08512, Manufactured by Sun Pharma Ind. Ltd. India, NDC 62756-015-40
Reason for recall
Presence of Particulate Matter
Distribution pattern
Nationwide
Code information
JKR0744A, JKR0745A, JKR0750A, JKR0795A; Exp. 09/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0611-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026